CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | Paterson Dan President and CEO | Sale 10b5-1 | −1,299 | $9.60 | $12K | 651,413 |
| 2026-10-01 | Paterson Dan President and CEO | Sale 10b5-1 | −44,121 | $8.00 | $353K | 652,712 |
| 2026-10-01 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −2,566 | $8.00 | $21K | 123,781 |
| 2026-09-21 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −55 | $7.70 | $424 | 118,014 |
| 2026-08-03 | Paterson Dan President and CEO | Sale 10b5-1 | −1,302 | $5.81 | $8K | 589,940 |
| 2026-06-22 | Paterson Dan President and CEO | Sale 10b5-1 | −20,871 | $4.18 | $87K | 591,242 |
| 2026-06-22 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −4,032 | $4.18 | $17K | 117,295 |
| 2026-06-22 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −57 | $4.13 | $235 | 117,238 |
| 2026-05-04 | Paterson Dan President and CEO | Sale 10b5-1 | −806 | $5.82 | $5K | 612,113 |
| 2026-02-04 | Paterson Dan President and CEO | Sale 10b5-1 | −970 | $6.69 | $6K | 612,919 |
| 2026-01-12 | Paterson Dan President and CEO | Sale 10b5-1 | −10,321 | $7.16 | $74K | 400,104 |
| 2026-01-12 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −5,039 | $7.16 | $36K | 104,719 |
| 2025-12-24 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −80 | $7.86 | $629 | 109,758 |
| 2025-12-16 | Stuglik Brian M Director | Sale 10b5-1 | −592 | $9.14 | $5K | 101,147 |
| 2025-12-16 | Paterson Dan President and CEO | Sale 10b5-1 | −393 | $9.14 | $4K | 410,425 |
| 2025-12-16 | Gagnon Robert E. Director | Sale 10b5-1 | −283 | $9.14 | $3K | 41,678 |
| 2025-12-11 | Paterson Dan President and CEO | Sale 10b5-1 | −2,000 | $10.00 | $20K | 410,818 |
| 2025-12-10 | Paterson Dan President and CEO | Sale 10b5-1 | −2,000 | $10.07 | $20K | 412,818 |
| 2025-12-09 | Paterson Dan President and CEO | Sale 10b5-1 | −2,000 | $10.25 | $21K | 414,818 |
| 2025-12-08 | Paterson Dan President and CEO | Sale 10b5-1 | −2,000 | $10.50 | $21K | 416,818 |
Page 1 of 8 · 160 trades